MK0533

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0533, covering 2015-06-23 to 2015-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005) [Phase 2]